104 related articles for article (PubMed ID: 33831356)
1. miR-93 regulates liver tumor initiating cells expansion and predicts chemotherapeutic response of patients.
Li J; Zhong X; Wang X; Xu F; Yang J; Lu J; Liu C; Lu J
Arch Biochem Biophys; 2021 May; 703():108871. PubMed ID: 33831356
[TBL] [Abstract][Full Text] [Related]
2. microRNA-29a regulates liver tumor-initiating cells expansion via Bcl-2 pathway.
Song S; Sun K; Dong J; Zhao Y; Liu F; Liu H; Sha Z; Mao J; Ding G; Guo W; Fu Z
Exp Cell Res; 2020 Feb; 387(2):111781. PubMed ID: 31857112
[TBL] [Abstract][Full Text] [Related]
3. miR-124 regulates liver cancer stem cells expansion and sorafenib resistance.
Feng Y; Jiang W; Zhao W; Lu Z; Gu Y; Dong Y
Exp Cell Res; 2020 Sep; 394(2):112162. PubMed ID: 32640195
[TBL] [Abstract][Full Text] [Related]
4. microRNA-454 promotes liver tumor-initiating cell expansion by regulating SOCS6.
Lei Z; Tang X; Si A; Yang P; Wang L; Luo T; Guo G; Zhang Q; Cheng Z
Exp Cell Res; 2020 May; 390(1):111955. PubMed ID: 32165166
[TBL] [Abstract][Full Text] [Related]
5. miR-613 inhibits liver cancer stem cell expansion by regulating SOX9 pathway.
Li B; Liu D; Yang P; Li HY; Wang D
Gene; 2019 Jul; 707():78-85. PubMed ID: 31075412
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways.
Xu Y; Huang J; Ma L; Shan J; Shen J; Yang Z; Liu L; Luo Y; Yao C; Qian C
Cancer Lett; 2016 Feb; 371(2):171-81. PubMed ID: 26655273
[TBL] [Abstract][Full Text] [Related]
7. MiR-128-3p overexpression sensitizes hepatocellular carcinoma cells to sorafenib induced apoptosis through regulating DJ-1.
Guo XL; Wang HB; Yong JK; Zhong J; Li QH
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6667-6677. PubMed ID: 30402839
[TBL] [Abstract][Full Text] [Related]
8. Cyclin G1 expands liver tumor-initiating cells by Sox2 induction via Akt/mTOR signaling.
Wen W; Han T; Chen C; Huang L; Sun W; Wang X; Chen SZ; Xiang DM; Tang L; Cao D; Feng GS; Wu MC; Ding J; Wang HY
Mol Cancer Ther; 2013 Sep; 12(9):1796-804. PubMed ID: 23804702
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of miR-137 reverses sorafenib resistance and cancer-initiating cell phenotypes by degrading ANT2 in hepatocellular carcinoma.
Lu AQ; Lv B; Qiu F; Wang XY; Cao XH
Oncol Rep; 2017 Apr; 37(4):2071-2078. PubMed ID: 28350139
[TBL] [Abstract][Full Text] [Related]
10. miR-365 regulates liver cancer stem cells via RAC1 pathway.
Jiang ZB; Ma BQ; Liu SG; Li J; Yang GM; Hou YB; Si RH; Gao P; Yan HT
Mol Carcinog; 2019 Jan; 58(1):55-65. PubMed ID: 30182377
[TBL] [Abstract][Full Text] [Related]
11. LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcription.
Lin Z; Xia S; Liang Y; Ji L; Pan Y; Jiang S; Wan Z; Tao L; Chen J; Lin C; Liang X; Xu J; Cai X
Theranostics; 2020; 10(19):8834-8850. PubMed ID: 32754282
[TBL] [Abstract][Full Text] [Related]
12. TARBP2-mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma.
Lai HH; Li CW; Hong CC; Sun HY; Chiu CF; Ou DL; Chen PS
Mol Oncol; 2019 Apr; 13(4):928-945. PubMed ID: 30657254
[TBL] [Abstract][Full Text] [Related]
13. miR-219 regulates liver cancer stem cell expansion via E-cadherin pathway.
Si A; Wang L; Miao K; Zhang R; Ji H; Lei Z; Cheng Z; Fang X; Hao B
Cell Cycle; 2019 Dec; 18(24):3550-3561. PubMed ID: 31724462
[TBL] [Abstract][Full Text] [Related]
14. miR-361-3p Regulates Liver Tumor-initiating Cells Expansion and Chemo-resistance.
Qu S; Zhang X; Wu Y; Li H; Zhai J; Wu D
J Cancer; 2021; 12(5):1483-1492. PubMed ID: 33531993
[TBL] [Abstract][Full Text] [Related]
15. miR-194 inhibits liver cancer stem cell expansion by regulating RAC1 pathway.
Ran RZ; Chen J; Cui LJ; Lin XL; Fan MM; Cong ZZ; Zhang H; Tan WF; Zhang GQ; Zhang YJ
Exp Cell Res; 2019 May; 378(1):66-75. PubMed ID: 30844391
[TBL] [Abstract][Full Text] [Related]
16. SNGH16 regulates cell autophagy to promote Sorafenib Resistance through suppressing miR-23b-3p via sponging EGR1 in hepatocellular carcinoma.
Jing Z; Ye X; Ma X; Hu X; Yang W; Shi J; Chen G; Gong L
Cancer Med; 2020 Jun; 9(12):4324-4338. PubMed ID: 32324343
[TBL] [Abstract][Full Text] [Related]
17. MiR-103 regulates hepatocellular carcinoma growth by targeting AKAP12.
Xia W; Ni J; Zhuang J; Qian L; Wang P; Wang J
Int J Biochem Cell Biol; 2016 Feb; 71():1-11. PubMed ID: 26646106
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-639 is Down-Regulated in Hepatocellular Carcinoma Tumor Tissue and Inhibits Proliferation and Migration of Human Hepatocellular Carcinoma Cells Through the KAT7/Wnt/β-Catenin Pathway.
Bai Z; Xia X; Lu J
Med Sci Monit; 2020 Jan; 26():e919241. PubMed ID: 31955177
[TBL] [Abstract][Full Text] [Related]
19. miR-122-mediated translational repression of PEG10 and its suppression in human hepatocellular carcinoma.
Shyu YC; Lee TL; Lu MJ; Chen JR; Chien RN; Chen HY; Lin JF; Tsou AP; Chen YH; Hsieh CW; Huang TS
J Transl Med; 2016 Jul; 14(1):200. PubMed ID: 27370270
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic modification of MiR-429 promotes liver tumour-initiating cell properties by targeting Rb binding protein 4.
Li L; Tang J; Zhang B; Yang W; LiuGao M; Wang R; Tan Y; Fan J; Chang Y; Fu J; Jiang F; Chen C; Yang Y; Gu J; Wu D; Guo L; Cao D; Li H; Cao G; Wu M; Zhang MQ; Chen L; Wang H
Gut; 2015 Jan; 64(1):156-67. PubMed ID: 24572141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
